Linda Burkly's most recent trade in Editas Medicine Inc was a trade of 710 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on Sept. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Editas Medicine Inc | Linda C. Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 03 Sep 2025 | 710 | 69,490 (0%) | 0% | 2.6 | 1,843 | Common Stock |
| Editas Medicine Inc | Linda C. Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 2.49 per share. | 31 Jul 2025 | 5,121 | 64,398 (0%) | 0% | 2.5 | 12,757 | Common Stock |
| Editas Medicine Inc | Linda C. Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 03 Jun 2025 | 726 | 69,519 (0%) | 0% | 1.7 | 1,252 | Common Stock |
| Editas Medicine Inc | Linda Burkly C. | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 275,100 | 275,100 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Linda Burkly C. | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Linda Burkly C. | EVP, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 04 Mar 2025 | 2,891 | 70,245 (0%) | 0% | 1.7 | 4,946 | Common Stock |
| Editas Medicine Inc | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 25 Jul 2024 | 11,886 | 73,136 (0%) | 0% | 5.4 | 64,370 | Common Stock |
| Editas Medicine Inc | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 74,400 | 74,400 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 24,800 | 69,967 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 15,055 | 85,022 (0%) | 0% | 0 | Common Stock | |
| Editas Medicine Inc | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 135,500 | 135,500 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 45,167 | 45,167 (0%) | 0% | 0 | Common Stock |